These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16908287)

  • 1. FK778 does not impair intestinal allograft absorption in a preclinical model of total small bowel transplantation.
    Zonta S; Doni M; Alessiani M; Abbiati F; Bardone M; Lovisetto F; Cobianchi L; Vigano J; De Martino M; Kabiri D; Dominioni T; Scaglione M; Bottazzi A; Poggi P; Dionigi P
    Transplant Proc; 2006; 38(6):1805-8. PubMed ID: 16908287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
    Zonta S; Alessiani M; Viganò J; Doni M; Bardone M; Dominioni T; De Martino M; Scaglione M; Vicini E; Filisetti C; Biroli A; Bottazzi A; Villa C; Morbini P; Dionigi P
    Transplant Proc; 2007; 39(6):2021-3. PubMed ID: 17692681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK778 and tacrolimus combination therapy to control acute rejection after pig intestinal transplantation.
    Alessiani M; Abbiati F; Zonta S; Zitelli E; Bardone M; Cobianchi L; Viganò J; Doni M; Mazzilli M; Dominioni T; Kabiri D; Bottazzi A; Morbini P; Molinaro MD; Dionigi P
    Transplant Proc; 2006; 38(6):1809-11. PubMed ID: 16908288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of malononitrilamide FK778 in a preclinical model of small bowel transplantation.
    Alessiani M; Zonta S; Abbiati F; Cobianchi L; Bardone M; Zitelli E; Doni M; Viganò J; Mazzilli M; Lovisetto F; Dominioni T; Dionigi B; Lusona B; Morbini P; Molinaro MD; Dionigi P
    Transplant Proc; 2005; 37(6):2719-21. PubMed ID: 16182793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study.
    Alessiani M; De Ponti F; Fayer F; Abbiati F; Zonta S; Zitelli E; Arbustini E; Morbini P; Poggi N; Klersy C; Blangetti I; Dionigi P; Zonta A
    Transpl Int; 2003 May; 16(5):327-35. PubMed ID: 12759724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elemental enteral nutrition preserves the mucosal barrier and improves the trophism of the villi after small bowel transplantation in piglets.
    Zonta S; Doni M; Alessiani M; Lovisetto F; Vigano J; Mazzilli M; Dominioni T; Podetta M; De Martino M; Scaglione M; Vicini E; Bottazzi A; Villa C; Morbini P; Dionigi P
    Transplant Proc; 2007; 39(6):2024-7. PubMed ID: 17692682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
    Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental small bowel transplantation from non-heart-beating donors: a large-animal study.
    Cobianchi L; Zonta S; Vigano J; Dominioni T; Ciccocioppo R; Morbini P; Bottazzi A; Mazzilli M; De Martino M; Vicini E; Filisetti C; Botrugno I; Dionigi P; Alessiani M
    Transplant Proc; 2009; 41(1):55-6. PubMed ID: 19249474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection.
    Guo WH; Tian L; Yuen ZW; Chan KL; Wo JY; Nicholls G; Dallman M; Tam PK
    J Pediatr Surg; 2000 Nov; 35(11):1600-5. PubMed ID: 11083432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High trough levels of oral FK506 induced by loss of small intestine.
    Sano N; Nio M; Shimaoka S; Ishii T; Amae S; Wada M; Ohi R
    Pediatr Transplant; 2001 Dec; 5(6):434-8. PubMed ID: 11737769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
    Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
    Deuse T; Hoyt G; Koyanagi T; Robbins RC; Schrepfer S
    Transplantation; 2008 Mar; 85(6):870-7. PubMed ID: 18360270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.